Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Kedudukan dalam Saham #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Harga Saham
$0.16240909
Disegerakkan terakhir: 2025-03-04
Modal Pasaran
$35.68M
Perubahan (1 hari)
0.27%
Perubahan (1 tahun)
0.00%
Negara
CN
Perdagangan Dali Pharmaceuticalco.,Ltd (603963)

Kategori

Pendapatan untuk Dali Pharmaceuticalco.,Ltd (603963)
Pendapatan pada Sep 2024 TTM: $-3.27M
Menurut laporan kewangan terkini Dali Pharmaceuticalco.,Ltd, pendapatan semasa syarikat ialah $-3.27M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-2.46M, peningkatan berbanding pendapatan pada tahun 2021 yang berjumlah $-6.54M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Dali Pharmaceuticalco.,Ltd dari 2012 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-3.27M 33.35%
2023 $-2.45M -0.43%
2022 $-2.46M -62.34%
2021 $-6.54M -1,232.14%
2020 $578.00K -76.49%
2019 $2.46M 34.05%
2018 $1.83M -77.19%
2017 $8.04M -23.55%
2016 $10.52M -6.56%
2015 $11.26M -40.72%
2014 $18.99M 6.67%
2013 $17.81M -0.04%
2012 $17.81M 0.00%
Pendapatan untuk syarikat atau pesaing serupa